Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Livro referente a dissertacao de mestrado realizada e defendida na Universidade do Estado do Rio de Janeiro e financiada pelas agencias CAPES, CNPq e FAPERJ. O estudo apresentou diversas alteracoes metabolicas advindas com a programacao metabolica de maes obesas e o tratamento com Bezafibrato, um medicamento ja utilizado na clinica e que a literatura cientifica descreve como agonista PAN-PPAR, mostrou melhoras significativas nas proles programadas. Desta forma, novas perspectivas de tratamento para a programacao fetal sao abertas assim como novos estudos passam a ser necessarios.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Livro referente a dissertacao de mestrado realizada e defendida na Universidade do Estado do Rio de Janeiro e financiada pelas agencias CAPES, CNPq e FAPERJ. O estudo apresentou diversas alteracoes metabolicas advindas com a programacao metabolica de maes obesas e o tratamento com Bezafibrato, um medicamento ja utilizado na clinica e que a literatura cientifica descreve como agonista PAN-PPAR, mostrou melhoras significativas nas proles programadas. Desta forma, novas perspectivas de tratamento para a programacao fetal sao abertas assim como novos estudos passam a ser necessarios.